Free Trial

ARS Pharmaceuticals (SPRY) Institutional Ownership

$8.12
-0.29 (-3.45%)
(As of 12:14 PM ET)

Institutional Ownership Changes (13F Filings) for ARS Pharmaceuticals (NASDAQ:SPRY)

Current
Institutional Ownership
Percentage
68.16%
Number of
Institutional Buyers
(last 12 months)
38
Total
Institutional Inflows
(last 12 months)
$91.13M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$32.68M
Get SPRY Insider Trade Alerts

Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

SPRY Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2024 Virtu Financial LLC20,201$206K0.0%N/A0.021%
5/17/2024 RA Capital Management L.P.10,860,977$111.00M1.4%+14.8%11.210%
5/16/2024 California State Teachers Retirement System32,658$334K0.0%-3.4%0.034%
5/16/2024 Levin Capital Strategies L.P.55,250$565K0.1%+5.7%0.057%
5/16/2024 AWM Investment Company Inc.100,000$1.02M0.1%N/A0.103%
5/16/2024 Jacobs Levy Equity Management Inc.277,706$2.84M0.0%+1,280.5%0.287%
5/16/2024 Paloma Partners Management Co10,093$103K0.0%N/A0.010%
5/15/2024 Public Employees Retirement System of Ohio16,800$172K0.0%N/A0.017%
5/10/2024 Vanguard Group Inc.2,886,455$29.50M0.0%+37.0%2.979%
5/8/2024 Russell Investments Group Ltd.5,897$60K0.0%N/A0.006%
5/7/2024 ClariVest Asset Management LLC272,956$2.79M0.3%N/A0.282%
5/7/2024 SG Americas Securities LLC11,606$119K0.0%N/A0.012%
5/3/2024 GSA Capital Partners LLP128,889$1.32M0.1%+11.7%0.133%
5/1/2024 Capstone Investment Advisors LLC72,322$739K0.0%N/A0.075%
4/30/2024 J.W. Cole Advisors Inc.13,900$142K0.0%N/A0.014%
4/29/2024 FAS Wealth Partners Inc.60,470$618K0.1%+31.5%0.063%
4/29/2024 China Universal Asset Management Co. Ltd.18,453$189K0.0%+66.2%0.019%
2/14/2024 Sectoral Asset Management Inc.354,641$1.94M0.8%-66.2%0.369%
2/13/2024 Tower Research Capital LLC TRC7,065$39K0.0%-80.2%0.007%
2/9/2024 Franklin Resources Inc.4,098,497$22.46M0.0%+5.9%4.269%
2/6/2024 AJOVista LLC7,822$43K0.1%N/A0.008%
2/6/2024 Levin Capital Strategies L.P.52,250$286K0.0%-61.0%0.054%
2/6/2024 Swiss National Bank66,000$362K0.0%-19.8%0.069%
1/25/2024 Nisa Investment Advisors LLC5,600$31K0.0%+22,300.0%0.006%
1/24/2024 China Universal Asset Management Co. Ltd.11,105$61K0.0%+352.7%0.012%
1/19/2024 Denali Advisors LLC87,500$480K0.1%N/A0.091%
1/10/2024 Charles Schwab Trust Co3,996,071$21.90M2.2%-5.9%4.163%
11/15/2023 Tejara Capital Ltd103,739$392K0.2%-22.3%0.108%
11/15/2023 RA Capital Management L.P.9,459,678$35.76M0.7%+214.3%9.854%
11/15/2023 Sectoral Asset Management Inc.1,049,191$3.97M0.8%-16.4%1.093%
11/14/2023 Rubric Capital Management LP639,203$2.42M0.1%-77.2%0.666%
11/13/2023 FMR LLC1,307,340$4.94M0.0%-72.0%1.362%
11/13/2023 Tejara Capital Ltd103,739$392K0.3%-22.3%0.108%
11/9/2023 Letko Brosseau & Associates Inc.36,000$136K0.0%N/A0.038%
11/8/2023 Janney Montgomery Scott LLC24,072$91K0.0%-39.8%0.025%
10/24/2023 Bank of New York Mellon Corp83,924$317K0.0%+9.1%0.088%
10/23/2023 FAS Wealth Partners Inc.45,970$174K0.0%+34.2%0.048%
10/20/2023 Charles Schwab Trust Co4,246,071$16.05M1.8%N/A4.443%
10/12/2023 Brendel Financial Advisors LLC19,125$72K0.1%N/A0.020%
10/11/2023 Vontobel Holding Ltd.260,684$985K0.0%-24.2%0.273%
Bigger Than NVIDIA? (Ad)

With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.

Get the full story here >>>
9/21/2023 Barclays PLC20,460$138K0.0%N/A0.021%
8/14/2023 Caption Management LLC73,400$492K0.0%N/A0.077%
8/11/2023 Sectoral Asset Management Inc.1,255,640$8.41M1.4%N/A1.325%
8/11/2023 Rubric Capital Management LP2,799,203$18.76M0.8%-19.6%2.954%
8/11/2023 Tejara Capital Ltd133,521$895K0.4%N/A0.141%
8/10/2023 Nicholas Investment Partners LP275,000$1.84M0.1%N/A0.290%
8/8/2023 FAS Wealth Partners Inc.34,250$229K0.0%N/A0.036%
8/7/2023 Royce & Associates LP463,700$3.11M0.0%+52.6%0.489%
8/4/2023 American International Group Inc.11,672$78K0.0%N/A0.012%
8/1/2023 Arizona State Retirement System10,606$71K0.0%N/A0.011%
7/31/2023 Levin Capital Strategies L.P.169,074$1.13M0.1%N/A0.178%
7/28/2023 Shell Asset Management Co.65,322$438K0.0%N/A0.069%
7/26/2023 Janney Montgomery Scott LLC39,969$268K0.0%N/A0.042%
7/25/2023 DekaBank Deutsche Girozentrale35,000$231K0.0%N/A0.037%
7/24/2023 Vontobel Holding Ltd.344,029$2.31M0.0%N/A0.363%
7/19/2023 Teacher Retirement System of Texas10,244$69K0.0%N/A0.011%
7/18/2023 Avantax Planning Partners Inc.32,174$216K0.0%N/A0.034%
6/1/2023 Prelude Capital Management LLC15,053$98K0.0%N/A0.016%
5/23/2023 Royce & Associates LP303,900$1.98M0.0%N/A0.321%
5/19/2023 SR One Capital Management LP4,012,903$26.12M8.9%N/A4.234%
5/16/2023 Baker BROS. Advisors LP2,006,451$13.06M0.1%N/A2.121%
(Data available from 1/1/2016 forward)

SPRY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SPRY shares?

During the previous two years, 46 institutional investors and hedge funds held shares of ARS Pharmaceuticals. The most heavily invested institutionals were RA Capital Management L.P. ($111.00M), Vanguard Group Inc. ($29.50M), SR One Capital Management LP ($26.12M), Franklin Resources Inc. ($22.46M), Charles Schwab Trust Co ($21.90M), Baker BROS. Advisors LP ($13.06M), and FMR LLC ($4.94M).Learn more on SPRY's institutional investors.

What percentage of ARS Pharmaceuticals stock is owned by institutional investors?

68.16% of ARS Pharmaceuticals stock is owned by institutional investors. Learn more on SPRY's institutional investor holdings.

Which institutional investors have been buying ARS Pharmaceuticals stock?

Of the 41 institutional investors that purchased ARS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($7.85M), Charles Schwab Trust Co ($4.25M), SR One Capital Management LP ($4.01M), Baker BROS. Advisors LP ($2.01M), Sectoral Asset Management Inc. ($1.26M), Vanguard Group Inc. ($779.97K), and Royce & Associates LP ($463.70K).

How much institutional buying is happening at ARS Pharmaceuticals?

Institutional investors have bought a total of 23,118,970 shares in the last 24 months. This purchase volume represents approximately $132.39M in transactions.

Which ARS Pharmaceuticals major shareholders have been selling company stock?

Of the 11 institutional investors that sold ARS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($3.36M), Rubric Capital Management LP ($2.84M), Sectoral Asset Management Inc. ($901.00K), Charles Schwab Trust Co ($250K), Vontobel Holding Ltd. ($83.35K), Levin Capital Strategies L.P. ($81.75K), and Tejara Capital Ltd ($59.56K).

How much institutional selling is happening at ARS Pharmaceuticals?

Institutional investors have sold a total of 7,636,528 shares in the last 24 months. This volume of shares sold represents approximately $32.68M in transactions.


This page (NASDAQ:SPRY) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners